Low density lipoprotein landmark trials: Difference between revisions

	Low Density Lipoprotein Microchapters
Home
Patient information
Overview
Historical Perspective
Classification
Physiology
Pathophysiology
Causes Low LDL High LDL
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Prognosis and Complications
Diagnosis
Laboratory Findings
Treatment
Medical Therapy
Landmark Trials
Future or Investigational Therapies
Case Studies
Case #1
Low density lipoprotein landmark trials On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Low density lipoprotein landmark trials All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Low density lipoprotein landmark trials
CDC on Low density lipoprotein landmark trials
Low density lipoprotein landmark trials in the news
Blogs on Low density lipoprotein landmark trials
Directions to Hospitals Treating Low density lipoprotein
Risk calculators and risk factors for Low density lipoprotein landmark trials

Revision as of 02:55, 29 September 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 25: / Line 25: @@
 |-
 |}
-* WOSCOPS
-* AFCAPS/TexCAPS
-* MEGA
-* ASCOT-LLA: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm
-* Jupiter
-* Heart Protection Study
-* ALLHAT: Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial
-* PROVE IT: Pravastatin or Atorvastatin Evaluation and Infection Therapy – Thrombolysis In Myocardial Infarction
-* PROSPER: Prospective Study of Pravastatin in the Elderly at Risk
 ==References==
 {{Reflist|2}}